DrugPatentWatch Database Preview
Valeant Intl Company Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the competitive landscape for VALEANT INTL, and what generic and branded alternatives to VALEANT INTL drugs are available?
VALEANT INTL has eight approved drugs.
Summary for Valeant Intl
| US Patents: | 0 |
| Tradenames: | 6 |
| Ingredients: | 4 |
| NDAs: | 8 |
Drugs and US Patents for Valeant Intl
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valeant Intl | RETIN-A | tretinoin | SWAB;TOPICAL | 016921-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | |||||
| Valeant Intl | WELLBUTRIN XL | bupropion hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021515-001 | Aug 28, 2003 | AB3 | RX | Yes | No | Start Trial | Start Trial | ||||
| Valeant Intl | BENZAMYCIN | benzoyl peroxide; erythromycin | GEL;TOPICAL | 050557-001 | Oct 26, 1984 | AB | RX | Yes | Yes | Start Trial | Start Trial | ||||
| Valeant Intl | RETIN-A | tretinoin | GEL;TOPICAL | 017955-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Valeant Intl
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Valeant Intl | RETIN-A MICRO | tretinoin | GEL;TOPICAL | 020475-002 | May 10, 2002 | 4,690,825 | Start Trial |
| Valeant Intl | WELLBUTRIN XL | bupropion hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021515-001 | Aug 28, 2003 | 6,096,341 | Start Trial |
| Valeant Intl | RETIN-A | tretinoin | GEL;TOPICAL | 017955-001 | Approved Prior to Jan 1, 1982 | 3,729,568 | Start Trial |
| Valeant Intl | RETIN-A MICRO | tretinoin | GEL;TOPICAL | 020475-001 | Feb 7, 1997 | 5,955,109 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for VALEANT INTL drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Gel | 0.04% | ➤ Subscribe | 2010-12-20 |
| ➤ Subscribe | Gel | 0.1% | ➤ Subscribe | 2010-07-08 |
| ➤ Subscribe | Extended-release Tablets | 150 mg and 300 mg | ➤ Subscribe | 2004-09-21 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
